6XT Stock Chart & Stats
€20.80
€0.00(0.00%)
At close: 4:00 PM EDT
€20.80
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€12.90 - €22.20
Previous CloseN/A
Volume0.00
Average Volume (3M)3.00
Market Cap
€5.39B
Enterprise Value€953.58K
Total Cash (Recent Filing)€59.80B
Total Debt (Recent Filing)€7.23B
Price to Earnings (P/E)30.9
Beta0.30
Next Earnings
Nov 12, 2026EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)114.80
Shares Outstanding265,332,300
10 Day Avg. Volume0
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)5.83
Price to Sales (P/S)6.95
P/FCF Ratio31.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.76
Revenue Forecast (FY)€868.57M
Bulls Say, Bears Say
Bulls Say
Revenue Growth And ProfitabilitySustained revenue expansion combined with strong gross and operating margins indicates effective product economics and operating leverage. The sharp 2026 profit improvement strengthens internal funding capacity, although durability should be monitored.
Conservative Balance SheetVery low leverage reduces refinancing risk and preserves flexibility to invest in product development, manufacturing capacity, and international expansion. A growing equity base also provides resilience if medical-device demand or profitability moderates.
Strong Recent Cash GenerationOperating cash flow exceeding reported earnings supports the quality of recent profits and gives the company resources for reinvestment without relying heavily on debt. This is particularly valuable in a specialized manufacturing business requiring ongoing development.
Bears Say
Uneven Free Cash Flow HistoryHistorical free-cash-flow inconsistency suggests working-capital needs, investment cycles, or other cash demands can materially reduce earnings conversion. This may limit the reliability of internally funded growth across different operating conditions.
Earnings VolatilityThe substantial year-to-year margin movement indicates that profitability is not yet uniformly predictable, even with healthy revenue growth. If cost, mix, or other operating factors reverse, recent earnings strength may prove less durable.
Procedure-Volume ExposureDemand is structurally linked to healthcare procedure volumes and adoption by clinicians, so slower procedure growth or delayed product uptake could constrain revenue. This exposure may also create uneven performance across geographies and procedure categories.
Asahi Intecc Co News
6XT FAQ
What was Asahi Intecc Co Ltd’s price range in the past 12 months?
Asahi Intecc Co Ltd lowest stock price was €12.90 and its highest was €22.20 in the past 12 months.
What is Asahi Intecc Co Ltd’s market cap?
Asahi Intecc Co Ltd’s market cap is €5.39B.
When is Asahi Intecc Co Ltd’s upcoming earnings report date?
Asahi Intecc Co Ltd’s upcoming earnings report date is Nov 12, 2026 which is in 71 days.
How were Asahi Intecc Co Ltd’s earnings last quarter?
Asahi Intecc Co Ltd released its earnings results on Aug 14, 2026. The company reported €0.11 earnings per share for the quarter, beating the consensus estimate of €0.093 by €0.017.
Is Asahi Intecc Co Ltd overvalued?
According to Wall Street analysts Asahi Intecc Co Ltd’s price is currently Overvalued.
Does Asahi Intecc Co Ltd pay dividends?
Asahi Intecc Co Ltd does not currently pay dividends.
What is Asahi Intecc Co Ltd’s EPS estimate?
Asahi Intecc Co Ltd’s EPS estimate is 0.22.
How many shares outstanding does Asahi Intecc Co Ltd have?
Asahi Intecc Co Ltd has 265,332,300 shares outstanding.
What happened to Asahi Intecc Co Ltd’s price movement after its last earnings report?
Asahi Intecc Co Ltd reported an EPS of €0.11 in its last earnings report, beating expectations of €0.093. Following the earnings report the stock price went down -1.905%.
Which hedge fund is a major shareholder of Asahi Intecc Co Ltd?
Currently, no hedge funds are holding shares in DE:6XT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Asahi Intecc Co Ltd
Asahi Intecc Co., Ltd. is a global enterprise dedicated to the research, manufacturing, and distribution of advanced medical devices. Its market reach extends across Japan, the United States, Europe, the Middle East, and China, with a significant international footprint. The company's diverse product range serves various medical specialties, including cardiology, where it supplies percutaneous transluminal coronary angioplasty (PTCA) guide wires, guiding catheters, balloon catheters, and penetration catheters. For peripheral, abdominal, and cerebrovascular systems, they provide specialized guide wires (including IVR guide wires and cerebrovascular system guide wires) and micro catheters. Additionally, Asahi Intecc produces guide wires and catheters vital for angiography procedures. Beyond its own brand, the company offers original equipment manufacturing (OEM) services for other medical device firms. It also manufactures a variety of medical and industrial components, such as element wires, stranded conductors, coils, tubes, and terminal processing products, specializing in the development and sale of ultra-fine stainless steel wire ropes and associated processed items. Founded in 1976 as Asahi Mini Rope Sales Co., Ltd., the company was renamed Asahi Intecc Co., Ltd. in July 1988 and is headquartered in Aichi, Japan.